A look at this week's top stories.
A study published in the journal Sleep and Breathing found sleep quality influenced newborn weight in a gender-specific and trimester-specific way.
A review of the risks, benefits, and indications for appropriate referral of fetal echocardiography
An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.
Understanding the effects is imperative for patient satisfaction.
In an effort to identify abnormal bleeding patterns and their prevalence and confirm existing and expected associations, a study was conducted as part of Apple’s larger Women’s Health Study.
Fertility myths and declining sexual satisfaction may contribute to shortfalls in contraceptive use after cancer treatment, a new study concludes.
Women in the late reproductive stage may experience menopause-related symptoms that could impact their quality of life, according to new research.
Labels of Plan B One-Step had previously stated—without scientific evidence—that the pill might block fertilized eggs from implanting in the womb.
The Food and Drug Administration (FDA) has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More